Home/ Supplements/ Vitamin D/ Hi-Stress B&C

Hi-Stress B&C

product on market Tablet or Pill Source Naturals Safety: 99/100
99/100

This product looks safe

  • Niacin: 164mg is 4.7× the Tolerable Upper Intake Level (35mg)
  • 53% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Vitamin C and D3 are supported by strong evidence for their roles in immune function and bone health. The remaining components, including carbohydrates and fiber, provide basic nutritional support. Overall, the ingredient profile is associated with a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 164mg is 4.7× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for Hi-Stress B&C
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
53%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
10 Calorie(s)
Total Carbohydrate
2 Gram(s) (7% DV)
Dietary Fiber
2 Gram(s) (7% DV)
Vitamin C
600 mg (667% DV)
1.7 mcg (9% DV)
Within RDA (0.1× RDA) 608 studies (A:16, B:251)
66 mg (5500% DV)
55.0× RDA — above typical dose 76 studies (A:0, B:33)
40 mg (3076% DV)
30.8× RDA — above typical dose 13 studies (A:0, B:1)
164 mg (1025% DV)
Exceeds UL by 4.7× (UL: 35 mg) 196 studies (A:5, B:63)
53 mg (3118% DV)
40.8× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
918 mcg (230% DV)
2.3× RDA — within safe limits 226 studies (A:10, B:105)
132 mcg (5500% DV)
55.0× RDA — above typical dose 139 studies (A:1, B:44)
133 mcg (443% DV)
4.4× RDA — above typical dose 27 studies (A:0, B:11)
316 mg (6337% DV)
63.2× RDA — above typical dose 2 studies — no high-quality reviews
69 mg (12% DV)
Within RDA (0.1× RDA) 38 studies (A:1, B:7)
Calcium
246 mg (19% DV)
322 mg (77% DV)
Within RDA (0.8× RDA) 316 studies (A:8, B:159)
Sodium
20 mg (1% DV)
Potassium
34 mg (1% DV)
400 mg
Market median: 300.0mg (214 products) 25 studies (A:0, B:6)
Jujube
350 mg
Catnip
333 mg
Skullcap
315 mg
GABA
250 mg
Hops Strobile
233 mg
200 mg
Market median: 400.0mg (142 products) 10 studies (A:0, B:2)
Market median: 250.0mg (60 products) 7 studies (A:0, B:1)
200 mg
Market median: 200.0mg (107 products)
133 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
100 mg
Market median: 250.0mg (337 products) 127 studies (A:1, B:41)
66 mg
Market median: 420.0mg (127 products) 4 studies (A:0, B:1)
66 mg
Market median: 500.0mg (223 products) 24 studies (A:0, B:1)
53 mg
Market median: 500.0mg (9 products) 7 studies — no high-quality reviews
50 mg
Market median: 500.0mg (180 products) 5 studies (A:0, B:1)
Lecithin
20 mg

Other Ingredients

Microcrystalline Cellulose Cellulose Gum Acacia Gum Stearic Acid Silica Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: 2 to 4 tablets as needed in response to environmental stress.

Warnings & Precautions

Contains soy.

Note: If you are pregnant, may become pregnant, or breastfeeding, consult your health care professional before using this product.

California Consumers: Warning: Reproductive harm - www.P65Warnings.ca.gov/food

Do not use if either tamper-evident seal is broken or missing.

Keep out of the reach of children.

Formulation Notes

Hi-Stress B&C with herbs

Periods of heightened stress may deplete the body's nutrient stores. This depletion may impede the system's ability to cope and perform effectively. Hi-Stress B&C helps restore nutrient levels during times of stress, bringing the body back to balance.

Metadata

Product Details

UPC / SKU0 21078 00524 7
DSLD Entry Date2022-11-22
Product TypeOther Combinations
FormTablet or Pill
DSLD ID274663
Data Updated2026-04-11
Research

Research Evidence

872
Research Sources
53
Avg Quality
309
Meta Analysis
309
Clinical Trial
111
Rct
71
Systematic Review
55
Guideline
4
Cochrane Review
4
Regulatory Source
2
Other
2
Narrative Review
2
Observational
1
Openfda Safety
A Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
A Vitamin D supplementation for prevention of mortality in adults
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Vitamin D supplementation for prevention of cancer in adults
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Interventions for preventing falls in older people in care facilities and hospitals
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Drugs for preventing lung cancer in healthy people
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Vitamin D supplementation for prevention of mortality in adults
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A High prevalence of vitamin D deficiency in Asia: A systematic review and meta-analysis
Meta Analysis Critical reviews in food science and nutrition 2023 PubMed DOI
A The effect of vitamin D supplementation on depressive symptoms in adults: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Critical reviews in food science and nutrition 2023 PubMed DOI
A Interventions for preventing falls in older people living in the community
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
View all evidence for Vitamin D →
Compare

Similar Products

View all Vitamin D products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.